Evidence map›Paper›PMID 39449917›Full record

ArticleCureus2024

Successful Combination Therapy of Optic Canal Decompression and Steroid Administration for Traumatic Optic Neuropathy in a 10-Year-Old Boy.

Hiroshi Fukumasa, Yurie Yamaga, Ryo Miyaoka, Masashi Kobayashi, Kazutaka Nishiyama

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroshi FukumasaDepartment of Pediatrics, Kitakyushu City Yahata Hospital, Kitakyushu, JPN.
Yurie YamagaDepartment of Critical Care and Anesthesiology, National Center for Child Health and Development, Tokyo, JPN.
Ryo MiyaokaDepartment of Neurosurgery, Hospital of the University of the Occupational and Environmental Health, Fukuoka, JPN.
Masashi KobayashiDepartment of Pediatrics, Kitakyushu City Yahata Hospital, Kitakyushu, JPN.
Kazutaka NishiyamaDepartment of Traumatology and Acute Critical Medicine, Osaka University Hospital, Osaka, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traumatic optic neuropathy (TON) is a rare complication caused by head injury in children. TON treatment has employed conservative treatment, steroid administration, and surgical procedures; however, which treatment is preferable remains controversial. We herein present a case of a 10-year-old boy with a TON-complicated head injury after falling from a two-meter-high slide in a park. Initial head computed tomography (CT) revealed the right optic canal fracture, and the patient complained of right visual impairment. He was diagnosed with TON, and surgical right optic canal decompression was performed at six hours post-injury. On postoperative day 2, his right visual acuity (VA) was 20/200, and his right eye developed a relative afferent pupillary defect, prompting a high-dose prednisolone administration. On day 12 post-injury, his right VA improved to 20/30. This clinical course suggests that a combined approach of optic canal decompression and steroid therapy was effective in this case. Further investigation is needed to identify optimal treatments that contribute to favorable visual outcomes for TON management in children. However, in pediatric patients, aggressive treatment may be warranted to prevent permanent visual impairment, with decisions made based on individual background factors and neurological symptoms.

Indexed as

optic nerve decompressionsystemic steroid therapytrauma pediatrictraumatic optic neuropathy (ton)treatment

Identifiers

PMID39449917
PMCPMC11501498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.